Literature DB >> 282087

The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension.

K Abe, M Yasujima, N Irokawa, M Seino, S Chiba, Y Sakurai, M Sato, Y Imai, K Saito, T Ito, T Haruyama, Y Otsuka, K Yoshinaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 282087     DOI： 10.1042/cs055363s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN： 0144-4107


× No keyword cloud information.
  6 in total

1.  Evidence for environmental familiality of kallikrein excretion in Utah kindreds.

Authors:  M M Dadone; J B Smith; D L Anderton; K O Ash; R R Williams
Journal:  West J Med       Date:  1986-05

2.  Changes in blood pressure, urinary kallikrein, and urinary prostaglandin E2 in rats with streptozotocin-induced diabetes.

Authors:  M Hayashi; S Senba; I Saito; W Kitajima; T Saruta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

3.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

4.  Arachidonic acid metabolites, hypertension and arteriosclerosis.

Authors:  P C Weber; W Siess; B Scherer; E Held; H Witzgall; R Lorenz
Journal:  Klin Wochenschr       Date:  1982-05-17

5.  Norepinephrine clearance and pressor effect in normal and hypertensive man.

Authors:  M Grimm; P Weidmann; G Keusch; A Meier; Z Glück
Journal:  Klin Wochenschr       Date:  1980-11-03

Review 6.  A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

Authors:  Makoto Katori; Masataka Majima
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.